bowen's FX Therapeutics Email Formats
Biotechnology Research • 
Vancouver, British Columbia, Canada • 1-10 Employees
Key Contact at bowen's FX Therapeutics
Eric Escobar
Vice President of Research And Development
Company overview
| Headquarters | Vancouver, BC V6C 3N2, CA |
| NAICS | 541714 |
| Keywords | Biotechnology, Drug Development, Fragile X Syndrome |
| Founded | 2024 |
| Employees | 1-10 |
About bowen's FX Therapeutics
Bowen's FX Therapeutics was founded by Jeff Parr following the diagnosis of his grandson, Bowen Parr with full mutation Fragile X Syndrome and Jeff’s desire to find a cure for Bowen and all who have Fragile X. Our lead program is an engineered Fragile X Messenger Ribonucleoprotein (FMRP) replacement strategy in Lead Optimization, with an aim of selecting a clinical candidate in 2025.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Vice President
Funding Data
bowen's FX Therapeutics has never raised funding before.
United Kingdom
Denmark
United States
Frequently asked questions
bowen's FX Therapeutics is located in Vancouver, British Columbia, CA.
bowen's FX Therapeutics was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.
bowen's FX Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
